SCHEMBL24872306

SCHEMBL24872306

CNCC(CCC(C)C)CC(C)C

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KISS1R Q969F8 3/20 0.35
KDM4E B2RXH2 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24446202 1.00 KISS1R (0.35) KISS1RKDM4E
SCHEMBL16264337 0.80 ALDH1A1 (0.39) KDM4E
SCHEMBL20056438 0.78
SCHEMBL22268686 0.78 CACNA2D1 (0.30)
SCHEMBL21983908 0.77 KISS1R (0.36) KISS1RKDM4E
SCHEMBL8579218 0.70 TRPM8 (0.32)
SCHEMBL20156127 0.70 LMNA (0.35) KISS1R
SCHEMBL28167341 0.69 TSHR (0.32)
SCHEMBL27320578 0.69 ANPEP (0.42)
SCHEMBL12039716 0.69 TSHR (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230010108-A1 A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP HANGZHOU DAC BIOTECH CO., LTD. (CN) 2023-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230010108-A1 A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP DAO, DDO, DCLRE1A KISS1R 3756/4885KDM4E 1781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.